当前位置:首页 - 行情中心 - 天新药业(603235) - 财务分析 - 现金流量表

天新药业

(603235)

  

流通市值:40.81亿  总市值:121.48亿
流通股本:1.47亿   总股本:4.38亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,526,360,406.881,038,942,294.14552,669,525.71,979,653,693.5
  收到的税费返还33,714,806.0732,510,657.2524,500,064.7744,580,451.09
  收到其他与经营活动有关的现金30,965,924.9219,626,775.8910,810,106.0885,064,026.35
  经营活动现金流入小计1,591,041,137.871,091,079,727.28587,979,696.552,109,298,170.94
  购买商品、接受劳务支付的现金602,565,918.36396,775,058.03195,687,630.9944,264,535.24
  支付给职工以及为职工支付的现金328,102,258.66247,736,143.65159,324,945.23407,114,151.4
  支付的各项税费127,272,810.2981,958,770.7342,275,173.48175,377,914.36
  支付其他与经营活动有关的现金42,549,971.4722,612,055.529,431,007.7282,885,715.47
  经营活动现金流出小计1,100,490,958.78749,082,027.93406,718,757.331,609,642,316.47
  经营活动产生的现金流量净额490,550,179.09341,997,699.35181,260,939.22499,655,854.47
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额17,159.2917,159.29-266,312.99
  收到的其他与投资活动有关的现金3,894,923,679.043,072,534,586.451,291,300,379.671,756,020,159.66
  投资活动现金流入小计3,894,940,838.333,072,551,745.741,291,300,379.671,756,286,472.65
  购建固定资产、无形资产和其他长期资产支付的现金484,625,516.62350,955,383.99188,366,271.991,066,956,760.36
  支付其他与投资活动有关的现金3,564,323,1882,744,322,000818,000,4622,230,000,000
  投资活动现金流出小计4,048,948,704.623,095,277,383.991,006,366,733.993,296,956,760.36
  投资活动产生的现金流量净额-154,007,866.29-22,725,638.25284,933,645.68-1,540,670,287.71
三、筹资活动产生的现金流量:
  取得借款收到的现金241,826,693.3202,488,961.1783,516,021.17297,432,594.11
  收到其他与筹资活动有关的现金10,366,596.126,700,900-14,997,516.17
  筹资活动现金流入小计252,193,289.42209,189,861.1783,516,021.17312,430,110.28
  偿还债务支付的现金1,000,0001,000,0001,000,000269,000,000
  分配股利、利润或偿付利息支付的现金301,900,354.65281,143,071.961,244,966.37220,188,546.56
  支付其他与筹资活动有关的现金-1,710,058.46-63,434,597.91
  筹资活动现金流出小计302,900,354.65283,853,130.422,244,966.37552,623,144.47
  筹资活动产生的现金流量净额-50,707,065.23-74,663,269.2581,271,054.8-240,193,034.19
四、汇率变动对现金及现金等价物的影响3,384,890.89,695,228.44-944,536.9551,705,671.71
五、现金及现金等价物净增加额289,220,138.37254,304,020.29546,521,102.75-1,229,501,795.72
  加:期初现金及现金等价物余额1,078,267,195.811,078,267,195.811,078,267,195.812,307,768,991.53
  期末现金及现金等价物余额1,367,487,334.181,332,571,216.11,624,788,298.561,078,267,195.81
补充资料:
  净利润-356,013,549.3-651,223,139.61
  资产减值准备-14,004,087.93-7,542,795.49
  固定资产和投资性房地产折旧-84,746,908.05-146,745,318.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-84,746,908.05-146,745,318.72
  无形资产摊销-2,282,689.98-4,509,353.8
  长期待摊费用摊销-918,032.19-1,385,837.04
  处置固定资产、无形资产和其他长期资产的损失-10,296.5--962.33
  固定资产报废损失-49,171.52-1,074,746.02
  公允价值变动损失--465,538.02--2,238,666.8
  财务费用--8,991,427.39--49,223,422.46
  投资损失--4,121,010.46--5,444,358.6
  递延所得税-2,108,248.23--2,050,619.82
  其中:递延所得税资产减少-2,108,248.23--2,050,619.82
  存货的减少--15,086,943.35--117,199,913.05
  经营性应收项目的减少-25,604,109.12--239,107,515.82
  经营性应付项目的增加--97,298,977.93-128,491,580.49
  其他--18,182,262.18--32,418,037.92
  不涉及现金收支的投资和筹资活动金额其他项目---0
  现金的期末余额-1,332,571,216.1-1,078,267,195.81
  减:现金的期初余额-1,078,267,195.81-2,307,768,991.53
  现金及现金等价物的净增加额-254,304,020.29--1,229,501,795.72
公告日期2025-10-312025-08-292025-04-302025-04-26
审计意见(境内)标准无保留意见
TOP↑